Struggle to include women in clinical trials continues despite gains

June 16, 2022

Though female participation in clinical trials has been steadily improving over the years, most of the women enrolled in trials are white and not members of minority groups. In addition, these studies must be designed and implemented with the ability to analyze whether the variables being studied affect women and minority groups differently than other participants.

Those are among the gender equity issues addressed at a June 15 panel at the 2022 Biotechnology Innovation Organization (BIO) International Convention in San Diego.

ScienceBoard.net spoke with BIO panelist Kathryn Schubert, president and CEO of the Society for Women's Health Research, which was founded 30 years ago to ensure that clinical trials were more inclusive of women and minority groups.

Despite improvements made when it comes to inclusion, Schubert pointed out that pregnant and lactating women are also typically underrepresented in clinical trials. She noted that these female populations were not initially included in COVID-19 vaccine trials, which created some confusion regarding whether the vaccines were safe and effective for them.

"Across the board, we need more women in science, whether they're clinical trial participants, researchers, clinicians, all the way up to the top level of executives at companies or throughout the federal government here in the U.S. We need women at the table to be able to create these trial designs and really think about the specific issues women are looking at," Schubert said.

Watch the video below to learn more.


Patient advocacy organizations look to partner with pharma companies
Patient advocacy organizations are looking to partner with pharmaceutical companies, offering resources and expertise to maximize the impact and efficiency...
How to develop a sustainable portfolio for cell, gene therapy platforms
Michael Retterath, a Biotechnology Innovation Organization International Convention 2022 panelist and chief business officer at Spark Therapeutics, spoke...
Biotech industry execs, not scientists, remain male-dominated
A panel at the 2022 Biotechnology Innovation Organization International Convention will explore how to close the gender gap in the biotech industry and...
The ‘voice of the patient’ needs to be heard in clinical trials: study
Patient recruitment and retention are among the biggest challenges facing clinical research, particularly in studies targeting rare diseases that have...
New era of non-viral DNA-delivered gene therapy seen emerging
Advancements in nucleic acid-encoded therapeutics over the past decade have sparked the emergence of a new era in non-viral DNA-delivered gene therapy,...
Biotech innovator recounts decades-long journey to create drug discovery technology
Dr. Stan Crooke, PhD, founder, chairman, and chief executive officer of RNA therapy company Ionis Pharmaceuticals, pioneered development of the antisense...
Biotech industry to gather at BIO International Convention in San Diego
More than 11,000 attendees from around the globe will be in San Diego, June 13-16, for the 2022 Biotechnology Innovation Organization (BIO) International...

Copyright © 2022 scienceboard.net

Last Updated 7/20/2022 2:31:29 PM